NBIS / Company research

Nebius Group earnings and filings

Financial results, original SEC reports and source-linked quarterly highlights.

SEC EDGAR / Collected

Reports and results announcements

FiledFormReport dateDocuments
20-F/A Dec 31, 2025 Annual reportAll exhibits and attachments
20-F Dec 31, 2025 Annual reportAll exhibits and attachments
20-F Dec 31, 2024 Annual reportAll exhibits and attachments
20-F Dec 31, 2023 Annual reportAll exhibits and attachments
20-F Dec 31, 2022 Annual reportAll exhibits and attachments
20-F Dec 31, 2021 Annual reportAll exhibits and attachments
20-F Dec 31, 2020 Annual reportAll exhibits and attachments
20-F/A Dec 31, 2019 Annual reportAll exhibits and attachments
20-F Dec 31, 2019 Annual reportAll exhibits and attachments
20-F/A Dec 31, 2018 Annual reportAll exhibits and attachments
20-F Dec 31, 2018 Annual reportAll exhibits and attachments
20-F May 4, 2018 Annual reportAll exhibits and attachments
20-F Dec 31, 2017 Annual reportAll exhibits and attachments
20-F Dec 31, 2016 Annual reportAll exhibits and attachments
20-F Dec 31, 2015 Annual reportAll exhibits and attachments
20-F Dec 31, 2014 Annual reportAll exhibits and attachments

An 8-K marked Item 2.02 announces results; the earnings release or presentation may be an exhibit under “All exhibits and attachments.” Filings are official source documents, not an audit performed by this publication.

NBIS annual investment, R&D and cash flow

Quarterly highlights and original SEC reports

Verified annual USD facts from SEC filings. Collected .

Annual period Revenue Cash capex Productive asset purchases Operating cash flow Free cash flow R&D R&D / revenue
to $529.8 million $4.07 billion Not available $384.8 million -$3.68 billion $177.3 million 33.5%
Revenues · 20-F filed · accession 0001104659-26-052948
NetCashProvidedByUsedInOperatingActivities · 20-F filed · accession 0001104659-26-052948
PaymentsToAcquirePropertyPlantAndEquipment · 20-F filed · accession 0001104659-26-052948
ResearchAndDevelopmentExpense · 20-F filed · accession 0001104659-26-052948
to $91.5 million $807.5 million Not available $245.6 million -$561.9 million $114.8 million 125.5%
Revenues · 20-F filed · accession 0001104659-26-052948
NetCashProvidedByUsedInOperatingActivities · 20-F filed · accession 0001104659-26-052948
PaymentsToAcquirePropertyPlantAndEquipment · 20-F filed · accession 0001104659-26-052948
ResearchAndDevelopmentExpense · 20-F filed · accession 0001104659-26-052948
to $9.8 million $82.9 million Not available $829.8 million $746.9 million $87.1 million 888.8%
Revenues · 20-F filed · accession 0001104659-26-052948
NetCashProvidedByUsedInOperatingActivities · 20-F filed · accession 0001104659-26-052948
PaymentsToAcquirePropertyPlantAndEquipment · 20-F filed · accession 0001104659-26-052948
ResearchAndDevelopmentExpense · 20-F filed · accession 0001104659-26-052948
to $13.5 million $14.6 million Not available $697 million $682.4 million $58.3 million 431.9%
Revenues · 20-F filed · accession 0001558370-25-005991
NetCashProvidedByUsedInOperatingActivities · 20-F filed · accession 0001558370-25-005991
PaymentsToAcquirePropertyPlantAndEquipment · 20-F filed · accession 0001558370-25-005991
ResearchAndDevelopmentExpense · 20-F filed · accession 0001558370-25-005991
SEC filing data: definitions, coverage and revisions

Source: the SEC Company Facts API, using standard US GAAP facts in USD from annual 10-K, 20-F or 40-F filings and amendments. Periods must span 300-400 days. Quarterly and year-to-date values are not presented as annual totals.

  • Cash capex is cash payments to acquire property, plant and equipment. It excludes broader acquisition or intangible-asset tags and is not total AI spending or an estimate of finance-lease investment.
  • Productive asset purchases are a separately reported, broader cash investment measure. They are shown in their own column and never substituted into PP&E capex, capital intensity or free cash flow. Do not rank mixed definitions as if they were identical.
  • Free cash flow here is operating cash flow minus cash capex. It may differ from a company's adjusted free cash flow definition. If either input is missing, the result is omitted.
  • R&D intensity is reported research and development expense divided by revenue from the same annual reporting period. Operating cash margin and capital intensity use the same-period revenue denominator.
  • Figures are company-wide, not AI-specific or segment-level. Financial years differ, so compare the displayed start and end dates rather than assuming calendar-year alignment.
  • The latest available filing for each supported fact is used, including restated comparative figures. Conflicting values from equally recent reports are omitted. Every figure retains its XBRL tag, accession and filing date.

Company-specific extension tags, IFRS-only data and unsupported definitions are not estimated. Missing standard facts are shown as unavailable, not zero. Data is refreshed in the background; the collection time is separate from the filing date.

Source: SEC EDGAR. Company-specific segment metrics and unsupported accounting tags are not estimated.